PGNX
Progenics Pharmaceuticals Inc
PGNX
PGNX
Delisted
PGNX was delisted on the 19th of June, 2020.
149 hedge funds and large institutions have $491M invested in Progenics Pharmaceuticals Inc in 2018 Q3 according to their latest regulatory filings, with 21 funds opening new positions, 64 increasing their positions, 32 reducing their positions, and 26 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding in top 10
Funds holding in top 10: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
17% less call options, than puts
Call options by funds: $7.33M | Put options by funds: $8.83M
19% less first-time investments, than exits
New positions opened: 21 | Existing positions closed: 26
Holders
149
Holding in Top 10
1
Calls
$7.33M
Puts
$8.83M
Top Buyers
| 1 | +$22.7M | |
| 2 | +$19M | |
| 3 | +$14.9M | |
| 4 |
BlackRock
New York
|
+$11.9M |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$9.42M |
Top Sellers
| 1 | -$7.87M | |
| 2 | -$3.62M | |
| 3 | -$2.71M | |
| 4 |
Fuller & Thaler Asset Management
San Mateo,
California
|
-$2.52M |
| 5 |
PA
Pinnacle Associates
New York
|
-$1.62M |